TherOZap Technology Test Results Prove Successful at Inhibiting Zika Virus During In-Vitro Tests
DGAP-News: Therma Bright Inc.
/ Key word(s): Miscellaneous
TherOZap(TM) Technology Test Results Prove Successful at Inhibiting Zika Virus During In-Vitro Tests 04.09.2019 / 12:33
The issuer is solely responsible for the content of this announcement.and www.coldsores.com
For further information please contact:Therma Bright Inc.Rob FiaCEO email@example.com
FORWARD LOOKING STATEMENTS
Certain statements in this news release constitute "forward-looking" statements. These statements relate to future events or the Company's future performance and include future testing of the Company's TherOZap? technology against the Zika virus and potentially other mosquito borne diseases, all as described in the news release. All such statements involve substantial known and unknown risks, uncertainties and other factors which may cause the actual results to vary from those expressed or implied by such forward-looking statements. In addition to other risks, the Company may not complete all or any of the tests as described in this news on the timelines described. Forward-looking statements involve significant risks and uncertainties, they should not be read as guarantees of future performance or results, and they will not necessarily be accurate indications of whether or not such results will be achieved. Actual results could differ materially from those anticipated due to a number of factors and risks. Although the forward-looking statements contained in this news release are based upon what management of the Company believes are reasonable assumptions on the date of this news release, the Company cannot assure investors that actual results will be consistent with these forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof and the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required under applicable securities regulations.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.
This press release is not an offer of the securities for sale in the United States. The securities have not been registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an exemption from registration. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/47497
Click on, or paste the following link into your web browser,to view the associated documents
http://www.newsfilecorp.com/release/47497 News Source: Newsfile
04.09.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.deLanguage: English Company: Therma Bright Inc.
Canada ISIN: CA8834261080 EQS News ID: 868507 End of News DGAP News Service